|
Volumn 9, Issue 3, 2008, Pages 301-309
|
Ilepatril (AVE-7688), a vasopeptidase inhibitor for the treatment of hypertension
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
AVE 7688;
AVE 8048;
BRADYKININ B2 RECEPTOR;
DIPEPTIDYL CARBOXYPEPTIDASE;
DRUG METABOLITE;
ENALAPRIL;
ENDOTHELIN 1;
ICATIBANT;
ILEPATRIL;
IRBESARTAN;
LISINOPRIL;
LOSARTAN;
NITRIC OXIDE;
PLACEBO;
RAMIPRIL;
UNCLASSIFIED DRUG;
VASOPEPTIDASE INHIBITOR;
ALBUMINURIA;
ANGIONEUROTIC EDEMA;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
DIABETIC NEPHROPATHY;
DOSE RESPONSE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HEART FAILURE;
HEART LEFT VENTRICLE FUNCTION;
HEART RATE;
HUMAN;
HYPERTENSION;
IN VITRO STUDY;
KIDNEY FIBROSIS;
MONOTHERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PATENT;
PODOCYTE;
PROTEINURIA;
RENAL PROTECTION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
SODIUM RESTRICTION;
SPONTANEOUSLY HYPERTENSIVE RAT;
STRUCTURE ACTIVITY RELATION;
TREATMENT DURATION;
VASODILATATION;
ZUCKER DIABETIC FATTY RAT;
ANIMALS;
ANTIHYPERTENSIVE AGENTS;
BLOOD VESSELS;
CLINICAL TRIALS AS TOPIC;
CLINICAL TRIALS, PHASE I AS TOPIC;
CLINICAL TRIALS, PHASE II AS TOPIC;
HETEROCYCLIC COMPOUNDS, 3-RING;
HUMANS;
PATENTS AS TOPIC;
PROTEASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 40049093528
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (14)
|
References (59)
|